secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2023-09-08T23:59:59+00:00
Accession:  0001193125-23-231557
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics receives Nasdaq bid price deficiency notice, 180 days to comply
--------------------------------------------------------------------------------

- Nasdaq notified TPST on Sept 6, 2023 that bid price closed below $1.00 for 30 consecutive days.
- Company has 180 calendar days, until March 4, 2024, to regain compliance.
- To comply, closing bid must be at least $1.00 for a minimum of ten consecutive business days.
- If not compliant by March 4, 2024, TPST may seek an additional 180-day period if eligible.
- Company states it will monitor bid price and evaluate options, including a reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312523231557/0001193125-23-231557-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312523231557/d532614d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-231557

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer